Heart failure (HF) remains a major global health burden. Vericiguat, a soluble guanylate cyclase stimulator, has been evaluated across HF phenotypes. However, trial results have been heterogeneous, leaving uncertainty regarding its clinical benefit. A Bayesian analysis would enable probabilistic estimation of tre...
P. Batista, R. R. A. Santos Silva, M. Montenegro et al.· European Heart Journal· 0 citations
Cardiovascular disease remains the leading cause of mortality in women, yet existing risk stratification tools frequently underestimate cardiovascular risk, particularly in younger and ostensibly low-risk populations. Breast arterial calcification (BAC), an incidental finding on routine screening mammography, has...
M. Malik, P. Batista, L. Lucena et al.· European Heart Journal· 0 citations
Diagnosing heart failure with preserved ejection fraction (HFpEF) remains challenging due to a broad spectrum of differential diagnoses. The left atrial coupling index (LACI) integrates the volume of the left atrium and the left ventricle at end-diastole and could be an echocardiographic marker to aid in a more a...
C. Bacca, J. Peres de Oliveira, R. Huntermann et al.· European Heart Journal· 0 citations
Chemotherapy-related cardiac dysfunction (CTRCD) is a major limitation of cardiotoxic cancer therapies. Although global longitudinal strain (GLS) allows early detection of myocardial injury, preventive strategies remain scarce. Angiotensin receptor–neprilysin inhibitors (ARNIs) may offer cardioprotection, but cur...
R. Huntermann, M. Molinari, P. Batista et al.· European Heart Journal· 0 citations
Peripartum cardiomyopathy (PPCM) remains an important cause of maternal morbidity and mortality, in part due to delayed recognition and limited feasibility of routine echocardiographic screening. Artificial intelligence (AI)–enabled electrocardiography (ECG) and digital auscultation tools have emerged as scalable...
R. Santos Silva, P. Batista, M. Montenegro et al.· European Heart Journal· 0 citations
Artificial intelligence (AI)–enabled monitoring has emerged as a promising approach for detecting atrial fibrillation (AF) recurrence after catheter ablation, providing continuous or high-frequency rhythm assessment beyond traditional ECG- and Holter-based follow-up. However, the diagnostic performance of AI-driv...
J. Giorgi, R. Huntermann, P. Batista et al.· European Heart Journal· 0 citations
Adverse pregnancy outcomes (APOs) - including hypertensive disorders of pregnancy (HDP), preeclampsia, gestational diabetes mellitus (GDM), preterm birth, and fetal growth deviations - are emerging female-specific cardiovascular risk factors, but their association with long-term maternal atrial fibrillation (AF)...
P. Batista, R. Huntermann, M. Montenegro et al.· European Heart Journal· 0 citations
BACKGROUND
Adverse pregnancy outcomes (APOs) - including hypertensive disorders of pregnancy, preeclampsia, gestational diabetes mellitus (GDM), preterm birth, and fetal growth deviations - are emerging female-specific cardiovascular risk factors, but their association with long-term maternal atrial fibrillation (AF) r...
P. Batista, R. Huntermann, M. Montenegro et al.· European Journal of Obstetri...· 0 citations
INTRODUCTION
Older adults face an increased risk of influenza-related complications, particularly cardiovascular (CV) events. The comparative effectiveness of high-dose inactivated influenza vaccine (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) for these outcomes remains uncertain.
METHODS
Data...
Larissa Araújo de Lucena, B. Hakkeem, N. Schettino Samad et al.· American Journal of Preventi...· 0 citations
Artificial intelligence-enabled ECG analysis demonstrates encouraging overall diagnostic accuracy for early identification of CTRCD, with high specificity and NPV, and larger studies are needed to clarify the role of AI-ECG as a complementary tool within cardio-oncology surveillance strategies.
M. Molinari, P. Batista, R. Huntermann et al.· European Heart Journal, Supp...· 0 citations
A paradigm of continued, lifelong GDMT is mandated for vast majority of HFimpEF patients as they remain vulnerable despite apparent recovery, and continuation of GDMT is essential to prevent relapse and improve survival.
T. Rehman, M. Faizan, Muhammad Waqas et al.· Critical Pathways in Cardiol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.